COVID-19 Update: Key Questions to Consider in Preparing Your Q1 2020 Form 10-Q and Earnings Release

April 28, 2020

Reading Time : 2 min

Public companies are considering key questions as they prepare first quarter 2020 disclosures in the COVID-19 era. In light of the April 8, 2020 joint public statement issued by the Chairman of the Securities and Exchange Commission (SEC) and the Director of the SEC’s Division of Corporate Finance (the Division) highlighting the importance of forward-looking COVID-19 disclosures for investors and markets (the Joint Statement), as well as the March 25, 2020 Division CF Disclosure Topic No. 9 providing guidance on the importance of assessing and disclosing the evolving impact of the COVID-19 pandemic (the Disclosure Guidance), U.S. reporting companies should evaluate these pronouncements and determine the appropriate scope and detail of their disclosures impacted by COVID-19 and related economic developments.

Several key questions follow for U.S. reporting companies to consider when preparing and issuing the first quarter 2020 Form 10-Q and earnings season.

  1. How has COVID-19 impacted your continuing operations, and what should be disclosed in your MD&A due to such impact?
  2. How has COVID-19 impacted your liquidity and access to capital, and what should be disclosed in your MD&A due to such impact?
  3. If the effects of COVID-19 have triggered an impairment, what type of disclosures are required?
  4. Are there any matters related to COVID-19 that should be disclosed in “Subsequent Events”?
  5. Should you add a risk factor addressing COVID-19?
  6. Have you been named party to a lawsuit or incurred any loss contingencies due to COVID-19?
  7. If your company’s disclosure controls and procedures and/or internal controls over financial reporting have been impacted by COVID-19, when are disclosures required?
  8. What discussion of COVID-19 should you include in your earnings release and earnings calls?
  9. Should you include COVID-19 impacts in your disclaimer regarding Forward-Looking Statements?
  10. Are you eligible to take advantage of the extended filing deadline for your 10-Q?

Contact Information

If you have any questions concerning this alert, please contact:

Alice Hsu
Email
New York
+1 212.872.1053

Kerry E. Berchem
Email
New York
+1 212.872.1095

Rosa A. Testani
Email
New York
+1 212.872.8115

Garrett A. DeVries
Email
Dallas
+1 214.969.2891

Cynthia May Mabry
Email
Houston
+1 713.220.8130

Paul V. Monsour
Email
Houston
+1 713.250.2142

Kevin W. Schott
Email
Houston
+1 713.250.2138
Tyler A. Conte
Email
Houston
+1 713.250.2101

Share This Insight

Related Services, Sectors, and Regions

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.